The role of lymphocyte subset analysis in defining the clinical evolution of multiple sclerosis

Carlo Lorenzo Cazzullo; Domenico Caputo; Angelo Ghezzi; Mauro Zaffaroni

doi:10.1159/000116121

The role of lymphocyte subset analysis in defining the clinical evolution of multiple sclerosis

Carlo Lorenzo Cazzullo, Domenico Caputo, Angelo Ghezzi, Mauro Zaffaroni

Fondazione Don Carlo Gnocchi Onlus

Research output: Contribution to journal › Article

Abstract

Thirty patients with definite multiple sclerosis (MS) were examined monthly for one year. Each time, neurological examination, clinical history and monoclonal-antibody-defined Τ cell subsets were evaluated. Particularly, the helper/suppressor ratio (T4/T8) and the T4/T8 test-to-test variability (ΔΤ4/Τ8) were considered in relation to the occurrence of clinical exacerbations. Statistically significant correlations were found between clinical course and laboratory parameters, suggesting a possible role of Τ cell subset analysis in defining the clinical evolution of MS.

Original language	English
Pages (from-to)	5-12
Number of pages	8
Journal	European Neurology
Volume	27
Issue number	1
DOIs	https://doi.org/10.1159/000116121
Publication status	Published - 1987

Fingerprint

Keywords

Clinical follow-up
Monoclonal antibodies
Multiple sclerosis
Τ cell subsets

ASJC Scopus subject areas

Clinical Neurology
Neurology

Cite this

Cazzullo, C. L., Caputo, D., Ghezzi, A., & Zaffaroni, M. (1987). The role of lymphocyte subset analysis in defining the clinical evolution of multiple sclerosis. European Neurology, 27(1), 5-12. https://doi.org/10.1159/000116121

@article{706b7b6a9c2e4f7695ef19fe8d5e4732,

title = "The role of lymphocyte subset analysis in defining the clinical evolution of multiple sclerosis",

abstract = "Thirty patients with definite multiple sclerosis (MS) were examined monthly for one year. Each time, neurological examination, clinical history and monoclonal-antibody-defined Τ cell subsets were evaluated. Particularly, the helper/suppressor ratio (T4/T8) and the T4/T8 test-to-test variability (ΔΤ4/Τ8) were considered in relation to the occurrence of clinical exacerbations. Statistically significant correlations were found between clinical course and laboratory parameters, suggesting a possible role of Τ cell subset analysis in defining the clinical evolution of MS.",

keywords = "Clinical follow-up, Monoclonal antibodies, Multiple sclerosis, Τ cell subsets",

author = "Cazzullo, {Carlo Lorenzo} and Domenico Caputo and Angelo Ghezzi and Mauro Zaffaroni",

year = "1987",

doi = "10.1159/000116121",

language = "English",

volume = "27",

pages = "5--12",

journal = "European Neurology",

issn = "0014-3022",

publisher = "S. Karger AG",

number = "1",

}

TY - JOUR

T1 - The role of lymphocyte subset analysis in defining the clinical evolution of multiple sclerosis

AU - Cazzullo, Carlo Lorenzo

AU - Caputo, Domenico

AU - Ghezzi, Angelo

AU - Zaffaroni, Mauro

PY - 1987

Y1 - 1987

N2 - Thirty patients with definite multiple sclerosis (MS) were examined monthly for one year. Each time, neurological examination, clinical history and monoclonal-antibody-defined Τ cell subsets were evaluated. Particularly, the helper/suppressor ratio (T4/T8) and the T4/T8 test-to-test variability (ΔΤ4/Τ8) were considered in relation to the occurrence of clinical exacerbations. Statistically significant correlations were found between clinical course and laboratory parameters, suggesting a possible role of Τ cell subset analysis in defining the clinical evolution of MS.

AB - Thirty patients with definite multiple sclerosis (MS) were examined monthly for one year. Each time, neurological examination, clinical history and monoclonal-antibody-defined Τ cell subsets were evaluated. Particularly, the helper/suppressor ratio (T4/T8) and the T4/T8 test-to-test variability (ΔΤ4/Τ8) were considered in relation to the occurrence of clinical exacerbations. Statistically significant correlations were found between clinical course and laboratory parameters, suggesting a possible role of Τ cell subset analysis in defining the clinical evolution of MS.

KW - Clinical follow-up

KW - Monoclonal antibodies

KW - Multiple sclerosis

KW - Τ cell subsets

UR - http://www.scopus.com/inward/record.url?scp=0023197788&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023197788&partnerID=8YFLogxK

U2 - 10.1159/000116121

DO - 10.1159/000116121

M3 - Article

C2 - 3622575

AN - SCOPUS:0023197788

VL - 27

SP - 5

EP - 12

JO - European Neurology

JF - European Neurology

SN - 0014-3022

IS - 1

ER -

Access to Document

10.1159/000116121